Reflections on a recent NEJM publication highlight the importance of identifying and addressing the pathologic process of ...

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

The first in-human trials for an artificial lamellar implant demonstrates the device’s potential to treat corneal edema.

Cryoablation, the destruction of malignant cancer cells by freezing them, is increasingly becoming an alternative to having ...

Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Patients with hereditary angioedema whose attacks impacted their larynx experienced on-demand relief within 1.29 hours with ...

Hereditary angioedema is a rare genetic disorder characterized by recurring episodes of severe swelling in various parts of ...

Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for subcutaneous (SC) administration via a wearable, single-use, pre-programmed on-body infusor for outpatient ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...

Additionally, Unity Biotechnology also announced 3 Yehia Hashad, MD, executive vice president of research and development and ...